Skip to main content
. Author manuscript; available in PMC: 2023 Apr 9.
Published in final edited form as: FASEB J. 2021 Aug;35(8):e21785. doi: 10.1096/fj.202100047R

FIGURE 8.

FIGURE 8

Schematic representation of the plausible mechanism of action for therapeutic effects of Cf-02 on ASLN. ASLN, accelerated, severe lupus nephritis; Cf-02, a novel benzamide-linked small molecule